2003
DOI: 10.1002/eji.200323611
|View full text |Cite
|
Sign up to set email alerts
|

The brain as an immune privileged site: dendritic cells of the central nervous system inhibit T cell activation

Abstract: Dendritic cells (DC) are unique in their ability to prime naive T cells and initiate adaptive immunity. In recent years, DC were identified in the inflamed central nervous system (CNS), but their role in the initiation or regulation of the tissue specific immune response is unknown. As shown here, DC isolated from mice with experimental autoimmune encephalomyelitis (EAE) exhibit a maturational phenotype similar to immature bone marrow-derived DC or splenic DC as characterized by intermediate surface MHC class … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

9
87
1

Year Published

2004
2004
2009
2009

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 103 publications
(97 citation statements)
references
References 37 publications
9
87
1
Order By: Relevance
“…The function of CNS-derived DC has been analyzed in murine models of autoimmune and infectious diseases, with a variety of functions observed for these DC, ranging from inhibition of T-cell activation [32] to promotion of disease spreading [33]. Likewise, TIDC in non-glioma tumors have been described as playing several roles in the anti-tumor response.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The function of CNS-derived DC has been analyzed in murine models of autoimmune and infectious diseases, with a variety of functions observed for these DC, ranging from inhibition of T-cell activation [32] to promotion of disease spreading [33]. Likewise, TIDC in non-glioma tumors have been described as playing several roles in the anti-tumor response.…”
Section: Discussionmentioning
confidence: 99%
“…Proliferation and inhibition assays were performed as described previously [32]. Briefly, CD4 1 T cells were isolated from BALB/c or OT-II spleens using anti-mouse CD4-biotin (BD Bioscience) and CELLection biotin binder beads (Dynal/Invitrogen, Basel, Switzerland).…”
Section: Proliferation Assaysmentioning
confidence: 99%
See 1 more Smart Citation
“…Human bcells express TRAIL receptors and sensitivity to TRAILinduced apoptosis can be amplified by inhibition of protein synthesis or removal of TRAIL-R3. 33 Finally, TRAIL has also been shown to mediate a regulatory function during the pathogenesis of experimental allergic encephalomyelitis (EAE), 34 an animal model for multiple sclerosis in humans. Apart from this impressive regulatory potential of TRAIL in the regulation of autoreactive lymphocytes, it cannot be excluded that TRAIL, similar to FasL, also participates in the direct tissue destruction observed in most autoimmune dieases.…”
Section: Role Of Trail In Immune Regulation Immunopathologies and Aumentioning
confidence: 99%
“…Up to now, regulatory DCreg were generated by culturing imDC in the presence of immunosuppressive cytokines such as IL-10 and TGF-b or immunomodulatory drugs [4][5][6], which does not represent the in vivo physiologic conditions of DCreg in the organ microenvironment. More and more data show that the microenvironment in certain tissues has the ability to induce DC development [7][8][9][10] and also affects the function of DC; for example, DC in brain and kidney display regulatory functions but not T-cell-activating functions [11,12]. Our previous studies demonstrate that endothelial splenic stromal cells, which are used to mimic the in vivo splenic microenvironment, can promote the proliferation of mature DC (maDC) [7] and hematopoietic stem cells [8], driving them to à These authors contributed equally to this work.…”
mentioning
confidence: 99%